Purpose: Although oral antibiotic therapy remains the most common treatment modality for chronic bacterial prostatitis (CBP), it is known to have problems, such as potential adverse effects and the development of bacterial resistance. We compared the effects of oral and local injection therapies, with fluoroquinolones, in patients diagnosed as having chronic bacterial prostatitis/seminal vesiculitis, from Tc-99m ciprofloxacin imaging. Materials and Methods: The study randomly included 79 patients with symptom of prostatitis, who also showed hot uptake in the prostate or seminal vesicle on Tc-99m ciprofloxacin imaging. A total of 53 patients received oral antibiotics for 3 months. In 26 patients, a local injection of ciprofloxacin into the p...
Purpose: To examine the incidence of infective complications post Transrectal Ultrasound Guided Pros...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (...
Chronic bacterial prostatitis (CBP) is frequently diagnosed in men of fertile age, and is characteri...
We previously demonstrated the safety and efficacy of fluoroquinolone-macrolide combination therapy ...
Purpose : To compare the antibiotic prophylaxis based on quinolone administered orally with a combi...
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men is principally defined...
Background: Mounting worldwide resistance trends make the use of fluoroquinolone (FQ) antibacterial ...
Background: Mounting worldwide resistance trends make the use of fluoroquinolone (FQ) antibacterial ...
Objective: To compare pre- and post-therapy symptom scores reported on the National Institute of Hea...
Objectives: To evaluate the efficacy of intraprostatic injection of prophylactic antibiotics for the...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Background: To assess the prophylactic effect of fosfomycin (FM) and ciprofloxacin combinations for ...
Chronic bacterial prostatitis (CBP, NIH category II) is a diffi- cult-to-eradicate, recurring, chron...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Purpose: To examine the incidence of infective complications post Transrectal Ultrasound Guided Pros...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (...
Chronic bacterial prostatitis (CBP) is frequently diagnosed in men of fertile age, and is characteri...
We previously demonstrated the safety and efficacy of fluoroquinolone-macrolide combination therapy ...
Purpose : To compare the antibiotic prophylaxis based on quinolone administered orally with a combi...
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men is principally defined...
Background: Mounting worldwide resistance trends make the use of fluoroquinolone (FQ) antibacterial ...
Background: Mounting worldwide resistance trends make the use of fluoroquinolone (FQ) antibacterial ...
Objective: To compare pre- and post-therapy symptom scores reported on the National Institute of Hea...
Objectives: To evaluate the efficacy of intraprostatic injection of prophylactic antibiotics for the...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Background: To assess the prophylactic effect of fosfomycin (FM) and ciprofloxacin combinations for ...
Chronic bacterial prostatitis (CBP, NIH category II) is a diffi- cult-to-eradicate, recurring, chron...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Purpose: To examine the incidence of infective complications post Transrectal Ultrasound Guided Pros...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (...